학술논문
Safety, Tolerability and Efficacy of Orelabrutinib, Once a Day, to Treat Chinese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Cell Leukemia
Document Type
Abstract
Author
Xu, Wei; Song, Yongping ; Li, Zengjun ; Yang, Shenmiao ; Liu, Lihong ; Hu, Yu ; Zhang, Wei ; Zhou, Jianfeng ; Gao, Sujun ; Ding, Kaiyang ; Zhang, Huilai ; Zhu, Zunmin ; Wang, Shunqing ; Xu, Bing ; Hu, Jianda; Liu, Ting; Ji, Chunyan ; Xia, Zhongjun; Li, Yan ; Wang, Xin; Xu, Zhixin ; Zhao, Renbin ; Zhang, Bin ; Zhu, Alan ; Li, Jianyong
Source
In Blood 13 November 2019 134 Supplement 1:4319-4319
Subject
Language
ISSN
0006-4971